Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 3 Study of GK664S (clobetasol propionate) in Moderate-to-Severe Scalp Eczema Dermatitis
jRCT2080224185Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clobetasol in atopic dermatitis (AD), sponsored by Maruho Co., Ltd. Started Dec 2018; status: completed.
02
Drugs
clobetasol
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080224185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224185.